Immunology and Microbiology
Virus
72%
Severe Acute Respiratory Syndrome Coronavirus 2
67%
Influenza Virus
60%
Influenzavirus A
54%
Influenza
43%
Influenza A Virus (H5N1)
42%
Cytotoxic T Cell
42%
Epitope
36%
Viral Disease
28%
COVID-19
20%
Neutralizing Antibody
18%
Cytotoxic T-Cell
18%
T Cell
18%
Cytokine
16%
Monoclonal Antibody
15%
Nucleoprotein
15%
Viral Load
14%
Influenza A Virus (H1N1)
13%
interferon
13%
CD8
12%
Aves
12%
Viral Replication
11%
Omicron Coronavirus Variant
11%
Receptor Binding
11%
Hemagglutinin
10%
Immunity
9%
Virology
9%
Spike
9%
Pathogenicity
9%
B Cell
9%
Infectious Agent
9%
Antibody Response
9%
Syrian Hamster
8%
DBA 2 Mouse
8%
Antigen Specificity
7%
Macaca
7%
Immunopathology
7%
Influenza Virus Hemagglutinin
6%
Influenza A Virus (H7N3)
6%
Reassortment
6%
Adoptive Immunity
5%
Tumor Necrosis Factor
5%
Serum (Blood)
5%
Peripheral Blood Mononuclear Cell
5%
Memory B Cell
5%
Pig
5%
Antiviral Activity
5%
Keyphrases
Influenza Virus
100%
COVID-19
81%
Virus
51%
Influenza-like Illness
34%
Cytotoxic T Lymphocytes
34%
Epitope
27%
Influenza
19%
H5N1
19%
Hamster
18%
H5N1 Virus
17%
Virus-specific
17%
H5N1 Influenza Virus
16%
Nucleoprotein
15%
CD8+ T Cells
15%
Virus-specific Cytotoxic T Lymphocytes
14%
Monoclonal Antibody
14%
Neutralizing Antibodies
13%
Vaccine Response
11%
Cytotoxic T Lymphocyte Epitope
11%
Severe Acute Respiratory Syndrome Coronavirus 2 Variants
11%
Vietnam
11%
Cytotoxic T Cell Response
10%
Influenza A
10%
Rational Discourse
9%
Bourbon Virus
9%
Virology
9%
Highly Pathogenic H5N1 Influenza Virus
9%
Respiratory Infection
9%
Human Influenza
9%
Syrian Hamster
9%
SARS-CoV-2 Variants
8%
Lung
8%
CD8+
8%
Ad26
8%
Severe Acute Respiratory Syndrome Coronavirus 2 Infection
8%
SARS-CoV-2 Infection
8%
C57BL
8%
HLA-A
8%
Receptor-binding Domain
7%
Virus Replication
7%
Weight Loss
7%
Macaque
7%
Omicron Variant
7%
Vaccine Protection
7%
Mucosal Vaccine
7%
Viral
7%
Severe Disease
7%
Hong Kong
6%
Pathogenicity
6%
XBB.1.5
6%